Reuters logo
BRIEF-Wuhan Hiteck Biological Pharma sees Q1 to Q3 of FY 2017 net profit up 10 pct to 20 pct
October 13, 2017 / 4:19 AM / 2 months ago

BRIEF-Wuhan Hiteck Biological Pharma sees Q1 to Q3 of FY 2017 net profit up 10 pct to 20 pct

Oct 13(Reuters) - Wuhan Hiteck Biological Pharma Co Ltd

* Sees Q1 to Q3 of FY 2017 net profit to increase by 10 percent to 20 percent, or to be 107.4 million yuan to 117.2 million yuan

* Says Q1 to Q3 of FY 2016 net profit was 97.7 million yuan

* Says increased income from sales of main product is the main reason for the forecast

Source text in Chinese: goo.gl/ndeiY4

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below